Neurovascular Stent Market Size, Share & Trends Analysis | Global | 2023-2029 | MedCore | Includes: Traditional Neurovascular Stents, Flow Diversion Stents, and 1 more

Neurovascular Stent Market Size, Share & Trends Analysis | Global | 2023-2029 | MedCore | Includes: Traditional Neurovascular Stents, Flow Diversion Stents, and 1 more

The global neurovascular stent market was valued at $555 million in 2022 and is expected to grow at a CAGR of 6.1% during the forecast period, reaching $840 million. The full report suite on the global neurovascular stent market includes traditional neurovascular stents, flow diversion stents, and intrasaccular stents, reflecting the diversity of products available in the market.

MARKET REPORT DATA TYPES INCLUDED

Unit Sales, Average Selling Prices, Market Size & Growth Trends

COVID-19 Impact Analysis

Market Drivers & Limiters
Market Forecasts Until 2029, and Historical Data to 2019
Recent Mergers & Acquisitions
Company Profiles and Product Portfolios
Leading Competitors

GLOBAL NEUROVASCULAR STENT MARKET INSIGHTS

One of the primary drivers of the neurovascular stent market is the continuous enhancement of stent technology. These advancements make stent procedures quicker and safer, lowering patient risk and minimizing physician resistance to stenting products. However, some older-generation neurosurgeons who are not accustomed to using neurovascular stents may exhibit bias towards this relatively new technology in the interventional neuroradiology market.

GLOBAL NEUROVASCULAR STENT MARKET SHARE INSIGHTS

Within the global market for neurovascular stent, there are three key market players – Medtronic, MicroVention, Stryker. In 2022, Medtronic was the leader in the global neurovascular stent market. It currently offers the Pipeline™Flex and the first-generation of the flow diverting stent.

MARKET SEGMENTATION SUMMARY

Global Traditional Stent Market
Global Flow Diversion Stent Market
Global Intrasaccular Stent Market

RESEARCH SCOPE SUMMARY

Regions: North America (Canada, United States), Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela), Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, U.K.), Central & Eastern Europe (Baltic States, Bulgaria, Croatia, Czech Republic, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Turkey, Ukraine), Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates), Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Philippines, Singapore, South Korea, Taiwan, Thailand, Vietnam), Africa (Algeria, Egypt, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda)
Base Year: 2022
Forecast: 2023-2029
Historical Data: 2019-2022
Quantitative Coverage: Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.
Qualitative Coverage: COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.
Data Sources: Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.

WHY CHOOSE IDATA?

Experts Only – iData has been around for over 17 years and is the trusted source of intelligence, and data-driven insights for key industry players. We are made up of specialists with a sole focus on medical devices, dental devices and pharmaceuticals. Our research and consulting field of endeavour never strays from the medical device industry and, because of this, we are the number one choice for leading companies in this field.

Global Coverage– iData’s unique methodology, and its expansion to over 70 countries world-wide, has made it one of the most viable sources of intelligence for global companies along with those who plan to expand their portfolio beyond the confines of their own country. Providing procedural data at the country level is another testimony to the trusted global coverage we provide.

Attention to Detail – It’s our attention to small details, scheduling of timelines, and keen project management that makes us stand out from the rest. We are creative, and our reports include metrics such as procedure numbers, ASPs, and SKU-level insights that are not found elsewhere.

Pricing– When comparing like-with-like, iData’s prices are not only extremely competitive but also the most cost-effective. We strive for success and want the same for our clients. With the level of detail incorporated into each report alongside the extensive segmentation provided, no other report compares at our price point.